James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 3,700 shares at $74.21 ($273K) on 2019-08-08, disclosed to the SEC on 2019-08-12.
Open-market sale of $273k GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.56 | 1,723 | $127K | 46.4% |
| 2 | $73.57 | 700 | $51K | 18.9% |
| 3 | $74.21 | 1,277 | $95K | 34.7% |
| Total | $73.79 avg | 3,700 | $273K | 100% |
| Filing → |
| GHDX | SELL | 2019-09-11 | $311K | — | Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-08-12 | $178K | — | Filing → |